.Accountable for the oversight and coordination of program and study level (re-)feasibility assessments in the country or extended country group (OPCs & satellite countries), in collaboration with program and/or trial feasibility teams, in compliance with Novartis processes, GCP, ICH and regulatory requirements. This position is key to establish good communication and professional relationships with clinical investigators and company stakeholders on country/cluster/hub/global level. Closely collaborates with rest of Study & Site Operations and relevant medical/clinical functions to ensure successful allocation, realistic country targets, recruitment according to planned timelines, early identification of risks and opportunities as well as potential delays and mitigation plan.About the RoleMajor Accountabilities:Single point of contact for communication between Clinical Operations Program Manager/Clinical Operations Program Head, country/extended country group Study & Site Operations teams and local relevant medical/clinical functions for all requests for program/study feasibility.Coordinates the feasibility activities on country/extended country group level by ensuring:Site identification and selection, trial feasibility evaluation.Collates/validates the list of potential sites by utilizing internal and external data (e.G., historical data, individual knowledge within local Study & Site Operations Team and relevant medical/clinical functions, internal and external databases).Manages the study specific feasibility questionnaire and sends to all participating sites together with any supporting documentation, if applicable.Follows up with sites to ensure questionnaires are answered and any additional feedback is obtained.Assesses the clinical feasibility of implementing a clinical trial protocol based on regional/local medical practice using physician interviews, local databases (RWE, payer data, patient association feed-back, etc.) and analysis of the competitive environment.Enters feedback into global database if applicable (e.G., CLIP).Collects, analyses, and interprets data to provide comprehensive proposals and timelines for country / extended country group allocation of clinical programs and assigned trials.Responsible for early identification of potential risks and opportunities as well as potential synergies and back-up strategies within the country/extended country group.Closely collaborates with the Study & Site Operations to ensure fast clinical trial start up, recruitment according to planned timelines, early identification of potential delays and robust recruitment mitigation plan. Co-owns start-up phase and the recruitment plan for development clinical trials with the Study & Site Operations organization.Key Performance Indicators:Timely submission of feasibility data.Performance against study commitments at the country level, including delivery of studies per defined number of patients and quality